Skip to main content
Moogene Medi Co., Ltd. logo

Moogene Medi Co., Ltd. — Investor Relations & Filings

Ticker · 322970 ISIN · KR7322970005 KO Manufacturing
Open in API
Filings indexed 183 across all filing types
Latest filing 2024-12-13 Regulatory Filings
Country KR South Korea
Listing KO 322970

About Moogene Medi Co., Ltd.

http://moogene.com/eng/

Moogene Medi Co., Ltd. is a biotechnology company specializing in nanomedicine and the development of advanced drug delivery systems. The company focuses on its proprietary Lipid Nanoparticle (LNP) carrier system and other nano-bio technologies to safely and effectively transport a range of therapeutic agents, including genes, chemicals, and proteins. Its primary mission is to create novel therapeutics for severe and incurable diseases. The development pipeline includes gene therapies for conditions such as cancer, metabolic diseases, and androgenic alopecia, utilizing technologies like CRISPR/Cas9 gene editing. Moogene Medi operates an aseptic, GMP-grade facility, providing end-to-end support from initial research to GMP-scale production for clinical studies.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of holding an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of the record date for shareholder rights. Given the nature of the announcement as a regulatory disclosure regarding meeting preparation, it falls under the general regulatory filing category.
2024-12-13 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 100% confidence The document is a formal notification of the results of an Investor Relations (IR) meeting held by the company. It provides details such as the date, time, location, attendees, and a summary of the topics discussed (company introduction, management status, and Q&A). Since it is a short announcement summarizing the occurrence and outcome of an IR event rather than the full presentation deck itself, it falls under the category of general regulatory announcements or reporting on corporate events.
2024-11-25 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is an official announcement regarding the scheduling of an Investor Relations (IR) meeting. It provides details such as the date, time, location, purpose, and target audience for the upcoming presentation. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like earnings releases or financial reports, it is classified as a Regulatory Filing (RNS) as it serves as a formal corporate disclosure.
2024-11-11 Korean
기타주요경영사항(자율공시)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Mujin Medi) regarding the submission of an Investigational New Drug (IND) application for a clinical trial. It is a voluntary disclosure of a material management event. Since it does not fit into specific categories like financial reports, dividends, or share transactions, and is a formal regulatory announcement of a business development, it is classified as a Regulatory Filing (RNS).
2024-10-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically '장내매수' or open-market purchases) made by an executive (CEO Yoon Tae-jong) of the company 'Moogene Medi'. This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which falls under the 'Director's Dealing' category.
2024-09-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in South Korea. It details the share transactions (specifically '장내매수' or open market purchases) by a company director (CEO Yoon Tae-jong). This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company executives.
2024-08-20 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.